Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FQVDJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,008
Award facts
- Contract value 100% obligated
- $2,007.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of DUPIXENT 300 mg/2 mL pen injections with a ceiling value of $2,007.95. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 26, 2025. As a child contract, this delivery order likely falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement needs through the Defense Logistics Agency's Medical Supply Chain. DUPIXENT (dupilumab) is a specialty biologic medication commonly used to treat moderate-to-severe atopic dermatitis, eczema, asthma, and other allergic conditions, and its inclusion in federal supply contracts reflects the Department of Defense's medical support requirements for service members and beneficiaries. The delivery order demonstrates the company's ongoing role in supplying specialty pharmaceutical products to military healthcare systems and underscores the importance of reliable supply chains for brand-name biologic medications within the federal medical procurement framework.
Quick answers
Who was awarded contract SPE2DB25FQVDJ?
SPE2DB25FQVDJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 25, 2025.
How much is contract SPE2DB25FQVDJ worth?
The government has obligated $2,008 on SPE2DB25FQVDJ.
Is contract SPE2DB25FQVDJ an order under another contract?
Yes. SPE2DB25FQVDJ is a delivery order under SPE2DB25D3001, an indefinite delivery contract.
Was contract SPE2DB25FQVDJ competed?
The extent of competition for SPE2DB25FQVDJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award